Activirosomes develops effective, safe and affordable vaccines and virotherapies against serious diseases. Our vision is to bring affordable modern medicine to global mass markets.
Active virosomes technology is a powerful and versatile platform that harnesses natural biological processes to produce inherently safe vaccines and therapies reliably, quickly and at lower cost than alternatives.
Activirosomes Limited is registered in England, with number 10543429. Active virosomes technology was developed by Seagull Biosolutions PVT Ltd.